Spots left: Abliva’s Fireside Chat in Lund and Stockholm
Abliva AB (Nasdaq Stockholm: ABLI), a clinical-stage biotech company developing medicines for the treatment of rare and severe primary mitochondrial diseases, invites interested shareholders and inves ...